Christiansen Shannon Ryan, Morgan Jill A, Hilmas Elora, Shepardson Adrienne
Department of Pharmacy, Seattle Children's Hospital, Seattle, Washington.
J Pediatr Pharmacol Ther. 2008 Oct;13(4):226-32. doi: 10.5863/1551-6776-13.4.226.
The purpose of this study was to determine if a prescription review service, at the time of discharge, enhances the accuracy and safety of prescriptions written at an academic pediatric hospital.
The study took place over a 30-day period and included prescriptions written for patients being discharged from the General Pediatric and Pediatric Intensive Care Services at the University of Maryland Hospital for Children, a 120-bed academic pediatric hospital. Discharge prescriptions were faxed to the Inpatient Pediatric Pharmacy where they were reviewed by a pediatric clinical pharmacist. Specific review criteria were aimed at detecting prescribing errors that included patient identification, medication selection, dosing, and therapy omission. A prescriber was notified via alpha page when errors were identified and advised on corrective measures. Interventions were compiled and analyzed to determine the overall impact of the discharge prescription review program.
Over the 30-day period, 74 discharge prescriptions were reviewed by a pediatric clinical pharmacist. At least one prescribing error was detected in 81% of the prescriptions reviewed. Overall, 101 prescribing errors were documented and included patient identification, medication selection and dose calculation errors. The estimated cost-savings attributed to the interventions is approximately $7670.
Through the discharge prescription review program, the pediatric clinical pharmacists were able to make interventions on the majority of prescriptions reviewed. The types of errors that required interventions have been identified as potential sources for major medication errors in the pediatric population. We concluded that the review of discharge prescriptions by a pediatric clinical pharmacist was an effective method of preventing prescribing errors in the pediatric environment.
本研究旨在确定出院时的处方审核服务能否提高一所学术性儿科医院所开处方的准确性和安全性。
本研究为期30天,纳入了马里兰大学儿童医院(一家拥有120张床位的学术性儿科医院)普通儿科和儿科重症监护服务科室出院患者的处方。出院处方被传真至住院儿科药房,由一名儿科临床药师进行审核。具体审核标准旨在发现包括患者识别、药物选择、剂量和治疗遗漏等方面的处方错误。当发现错误时,通过字母传呼通知开处方者并就纠正措施提供建议。对干预措施进行整理和分析,以确定出院处方审核项目的总体影响。
在这30天期间,一名儿科临床药师审核了74份出院处方。在审核的处方中,81%至少发现了一处处方错误。总体而言,记录了101处处方错误,包括患者识别、药物选择和剂量计算错误。因干预措施估计节省的费用约为7670美元。
通过出院处方审核项目,儿科临床药师能够对大多数审核过的处方进行干预。需要干预的错误类型已被确定为儿科人群中重大用药错误的潜在来源。我们得出结论,儿科临床药师对出院处方进行审核是预防儿科环境中处方错误的有效方法。